India's Strides Pharma gains on posting Q3 profit

Strides Pharma Science

30/01/2024 08:25

** Shares of Strides Pharma Science  SRID.NS  up 3.4%,
easing from a jump of as much as 6.2% after Q3 results
    ** The pharma company reported a Q3 profit vs a year-ago
loss, aided by high revenue from U.S. ops   
    ** Stock has been trading above its 100-, 200- day simple
moving average since April 2023
    ** Stock now up just over 8% YTD; its soared ~86% in 2023
after two years of losses

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))